Lawrence S Olanoff's Net Worth

$21.1 Million

Estimate Recalculated Oct 31, 2024 11:59PM EST

Who is Lawrence S Olanoff

Lawrence S Olanoff has an estimated net worth of $21.1 Million. This is based on reported shares across multiple companies, which include FOREST LABORATORIES INC, Imunon, Inc., IRONWOOD PHARMACEUTICALS INC, and Axovant Sciences Ltd..

SEC CIK

Lawrence S Olanoff's CIK is 0001224341

Past Insider Trading and Trends

2004 was Lawrence S Olanoff's most active year for acquiring shares with 5 total transactions. Lawrence S Olanoff's most active month to acquire stocks was the month of November. 2014 was Lawrence S Olanoff's most active year for disposing of shares, totalling 8 transactions. Lawrence S Olanoff's most active month to dispose stocks was the month of November. 2004 saw Lawrence S Olanoff paying a total of $3,024,814.40 for 373,000 shares, this is the most they've acquired in one year. In 2004 Lawrence S Olanoff cashed out on 566,200 shares for a total of $20,100,973.14, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Forest Laboratories, LLC

President and COO
Updated Jul 03, 2014
Form 4
-100.00%
-345.62K
Jul 03, 2014
Disposition
Jul 01
Form 4
-1.19%
-1.10K
$42.96
-$47.43K
Aug 27, 2013
91.35K
Sale
Aug 26
Form 4
8.46%
7.67K
Aug 16, 2013
98.37K
Grant
Aug 15
Form 4
-0.60%
-543.00
$36.77
-$19.97K
Mar 04, 2013
90.70K
Sale
Mar 04
Form 4
-0.61%
-561.00
$34.90
-$19.58K
Sep 06, 2012
91.24K
Sale
Sep 05
Form 4
11.14%
9.99K
Aug 27, 2012
99.62K
Grant
Aug 23
Form 4
-0.62%
-561.00
$32.39
-$18.17K
Mar 09, 2012
89.63K
Sale
Mar 07
Form 4
-19.07%
-21.25K
Oct 03, 2011
90.19K
Disposition
Dec 31
Form 4
2.22%
7.79K
Aug 25, 2011
359.44K
Grant
Aug 23
Form 4
-4.51%
-16.60K
Dec 22, 2010
351.65K
Grant
Dec 20
Form 4
-2.55%
-9.64K
$32.12
-$309.77K
Dec 10, 2010
368.24K
Tax
Dec 08
Form 4
-5.07%
-20.17K
$32.20
-$649.31K
Dec 09, 2010
377.89K
Tax
Dec 07
Form 4
-1.12%
-4.50K
$32.17
-$144.61K
Dec 08, 2010
398.06K
Tax
Dec 06
Form 4
-2.28%
-9.40K
$24.97
-$234.60K
Jun 09, 2010
402.55K
Tax
Jun 07
Form 4
-4.96%
-21.49K
$30.77
-$661.19K
Dec 10, 2009
411.95K
Tax
Dec 08
Form 4
47.17%
166.16K
$31.44
-$120.91K
Dec 09, 2009
518.44K
Grant
Dec 06 - Dec 07
Form 4
-2.52%
-9.10K
$23.44
-$213.16K
Jun 10, 2009
352.28K
Tax
Jun 08
Form 4/A
-1.21%
-4.44K
$22.96
-$102.01K
Jan 14, 2009
361.38K
Tax
Dec 06
Form 4
50.75%
147.19K
$29.32
-$229.13K
Dec 09, 2008
437.19K
Grant
Jun 06 - Dec 08
Form 4/A
75.00K
Jan 29, 2008
75.00K
Grant
Dec 06
Form 4
46.00%
115.00K
Dec 10, 2007
365.00K
Grant
Dec 06
Form 4
250.00K
Oct 31, 2006
250.00K
Grant
Oct 30
Form 3
Oct 31, 2006
7.55K
Form 4
75.00K
Dec 21, 2004
75.00K
Grant
Dec 13
Form 4
-46.04%
-268.20K
$42.55
-$17.08M
Feb 12, 2004
314.28K
Sale
Feb 10
Form 4
75.00K
Dec 16, 2003
75.00K
Grant
Dec 12
Showing 26 results

Imunon, Inc.

President & CEO
Updated Mar 16, 2006
Form 4
8.55%
37.51K
Mar 16, 2006
476.12K
Grant
Mar 15
Form 4/A
122.63%
76.64K
$0.33
$24.99K
Nov 30, 2005
139.15K
Purchase
Nov 14
Form 4
76.64K
$0.33
$24.99K
Nov 15, 2005
76.65K
Purchase
Nov 14
Form 4
6.44M
Jul 29, 2005
6.44M
Grant
Jul 29
Form 3
Jul 29, 2005
62.50K
Showing 5 results

IRONWOOD PHARMACEUTICALS INC

Investor
Updated Jun 04, 2021
Form 4
33.17%
22.77K
Jun 04, 2021
91.40K
Grant
Jun 02
Form 4
-14.19%
-11.35K
$10.06
-$114.18K
Jun 12, 2020
68.63K
Sale
ScheduledJun 10
Form 4
37.28%
21.72K
Jun 05, 2020
79.98K
Grant
Jun 03
Form 4
-3.32%
-2.00K
$11.25
-$22.50K
Jun 07, 2019
58.26K
Sale
ScheduledJun 05
Form 4
60.46%
22.71K
May 31, 2019
60.26K
Grant
May 29
Form 4
-5.06%
-2.00K
$14.41
-$28.82K
Mar 06, 2019
37.55K
Sale
ScheduledMar 05
Form 4
-4.81%
-2.00K
$12.47
-$24.94K
Dec 10, 2018
39.55K
Sale
ScheduledDec 06
Form 4
-4.59%
-2.00K
$19.10
-$38.20K
Sep 07, 2018
41.55K
Sale
ScheduledSep 05
Form 4
-4.39%
-2.00K
$17.62
-$35.24K
Jun 07, 2018
43.55K
Sale
ScheduledJun 05
Form 4
55.31%
16.22K
Jun 04, 2018
45.55K
Grant
May 31
Form 4
-6.38%
-2.00K
$14.05
-$28.10K
Mar 06, 2018
29.33K
Sale
ScheduledMar 05
Form 4
-6.00%
-2.00K
$16.46
-$32.92K
Dec 06, 2017
31.33K
Sale
ScheduledDec 04
Form 4
-5.66%
-2.00K
$16.15
-$32.30K
Sep 07, 2017
33.33K
Sale
ScheduledSep 05
Form 4
-8.31%
-3.20K
$17.78
-$56.90K
Jun 12, 2017
35.33K
Sale
ScheduledJun 08
Form 4
68.22%
15.63K
Jun 02, 2017
38.53K
Grant
May 31
Form 4
-12.26%
-3.20K
$17.19
-$55.01K
Mar 07, 2017
22.91K
Sale
ScheduledMar 03
Form 4
-10.92%
-3.20K
$15.68
-$50.18K
Dec 07, 2016
26.11K
Sale
ScheduledDec 05
Form 4
-9.84%
-3.20K
$13.72
-$43.90K
Sep 07, 2016
29.31K
Sale
ScheduledSep 06
Form 4
-6.34%
-2.20K
$12.92
-$28.42K
Jun 06, 2016
32.51K
Sale
ScheduledJun 03
Form 4
214.61%
23.67K
Jun 03, 2016
34.71K
Grant
Jun 01
Form 4
-16.63%
-2.20K
$11.11
-$24.44K
Mar 09, 2016
11.03K
Sale
ScheduledMar 07
Form 4
-14.26%
-2.20K
$11.77
-$25.89K
Dec 08, 2015
13.23K
Sale
ScheduledDec 07
Form 4
-19.45%
-3.73K
$10.97
-$40.86K
Sep 09, 2015
15.43K
Sale
Sep 04
Form 4
636.77%
16.56K
Jun 05, 2015
19.16K
Grant
Jun 03
Form 4
2.60K
Apr 16, 2015
2.60K
Grant
Apr 16
Form 3
Apr 16, 2015
Showing 26 results

Axovant Sciences Ltd.

Investor
Updated May 02, 2017
Form 4
27.00K
May 02, 2017
27.00K
Grant
Apr 28
Form 4
47.00K
May 03, 2016
47.00K
Grant
Apr 29
Form 4
75.00K
Jun 24, 2015
75.00K
Grant
Jun 22
Form 3
Jun 10, 2015
Showing 4 results